Predictors of prostate cancer detection using an extended biopsy regimen in patients with a total PSA between 2.5 and 4.0ng/ml

被引：0
|
作者：
Stephenson, AJ
Singh, H
Canto, EI
Shariat, SF
Kattan, MW
Scardino, PT
Kadmon, D
Miles, BJ
Wheeler, TM
Slawin, KM
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)37901-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [41] Cumulative probability of prostate cancer detection in biopsy according to free/total PSA ratio in men with total PSA levels of 2.1–10.0 ng/ml at population screening
    Yasuhide Kitagawa
    Satoru Ueno
    Kouji Izumi
    Yoshifumi Kadono
    Hiroyuki Konaka
    Atsushi Mizokami
    Mikio Namiki
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 53 - 59
  • [42] THE [2]PROPSA AND THE PROSTATE HEALTH INDEX (PHI) IMPROVE THE DETECTION OF PROSTATE CANCER FOR PATIENTS WITH TOTAL PSA BETWEEN 1 8 AND 80 NG/ML
    Blanchet, J. S.
    Houlgatte, A.
    Durand, X.
    Ramirez, J. N.
    Bensalah, K.
    Guille, B.
    Vincendeau, S.
    JOURNAL OF MENS HEALTH, 2010, 7 (03) : 345 - 345
  • [43] ProPSA (pPSA) in relation to free PSA gives the best performance in detecting cancer in the 2.5-4.0 ng/mL total PSA range
    Sokoll, LJ
    Partin, AW
    Mohr, P
    Mikolajczyk, SD
    Rittenhouse, HG
    Evans, CL
    Linton, HJ
    Marks, LS
    Bartsch, G
    Klocker, H
    Horninger, W
    Chan, DW
    JOURNAL OF UROLOGY, 2002, 167 (04): : 286 - 286
  • [44] THE ISOFORM [-2]PROPSA AND THE PROSTATE HEALTH INDEX (PHI) IMPROVE THE DETECTION OF PROSTATE CANCER FOR PATIENTS WITH TOTAL PSA BETWEEN 1.8 AND 8.0 NG/ML
    Blanchet, J-S
    Houlgatte, A.
    Durand, X.
    Ramirez, J. N.
    Bensalah, K.
    Guille, B.
    Vincendeau, S.
    TUMOR BIOLOGY, 2010, 31 : S120 - S120
  • [45] Ratio free/total PSA (%f-PSA) in men with total PSA 0.5–3 ng/ml: Improvement for prostate cancer detection?
    Hammerer P.
    Graefen M.
    Henke R.P.
    Haese A.
    Hul E.
    Huland H.
    Prostate Cancer and Prostatic Diseases, 2000, 3 (Suppl 1) : S19 - S19
  • [46] PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml - Editorial comment
    Bartsch, G
    UROLOGY, 2002, 59 (06) : 893 - 894
  • [47] The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng./ml.: Relation to biopsy strategy
    Babaian, RJ
    Johnston, DA
    Naccarato, W
    Ayala, A
    Bhadkamkar, VA
    Fritsch, HA
    JOURNAL OF UROLOGY, 2001, 165 (03): : 757 - 760
  • [48] Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml.
    Okihara, K
    Fritsche, HA
    Ayala, A
    Johnston, DA
    Allard, WJ
    Babaian, RJ
    JOURNAL OF UROLOGY, 2001, 165 (06): : 1930 - 1936
  • [49] Accuracy of percent free PSA to predict prostate cancer diagnosis in men with total PSA ranges lower than 2.5 ng/ml
    Haese, A.
    Walz, J.
    Gallina, A.
    Steuber, T.
    Briganti, A.
    Chun, F.
    Graefen, M.
    Montorsi, F.
    Huland, H.
    Karakiewicz, P. I.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 50 - 50
  • [50] Correlation of prostate volume and percent free PSA in prostate cancer detection in men with a total PSA 2.6-10.0 ng/ml
    Bruno, JJ
    Armenakas, NA
    Fracchia, JA
    JOURNAL OF UROLOGY, 2006, 175 (04): : 478 - 479
12345